688026 洁特生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.7216.1523.0308.30919.354
总资产报酬率 ROA (%)3.3214.3382.1536.29715.920
投入资产回报率 ROIC (%)3.5814.6612.3046.91818.018

边际利润分析
销售毛利率 (%)42.17441.41330.62231.84241.914
营业利润率 (%)16.55417.1378.51715.75724.649
息税前利润/营业总收入 (%)20.96919.3609.37114.89123.574
净利润/营业总收入 (%)14.72313.0607.57914.38020.003

收益指标分析
经营活动净收益/利润总额(%)87.511107.722112.525102.048125.500
价值变动净收益/利润总额(%)2.918-1.048-2.077-1.7061.027
营业外收支净额/利润总额(%)-0.122-0.123-2.9321.954-7.804

偿债能力分析
流动比率 (X)7.8646.6837.4567.0223.949
速动比率 (X)6.4655.5956.6395.9893.096
资产负债率 (%)28.75329.67028.81028.97917.674
带息债务/全部投入资本 (%)22.68022.42222.56521.4362.909
股东权益/带息债务 (%)334.118338.665335.003357.0043,191.900
股东权益/负债合计 (%)246.113235.608246.970244.923465.798
利息保障倍数 (X)4.7288.6258.550-12.62533.253

营运能力分析
应收账款周转天数 (天)105.434101.81990.36872.62447.190
存货周转天数 (天)158.737117.855117.256107.36977.332